• Manufacturing at pharmaceutical units continues to be impacted courtesy of lockdown-driven disruption
• All the pharmaceutical companies are facing challenges in distribution, manufacturing and logistics
• Industry experts have predicted growth of 1-5 percent in the domestic retail market
The domestic pharma retail market has witnessed one of the sharpest falls in three years ....
Tags : Pharma news, COVID-19 impact, lockdown, acute therapies, chronic medicines,